Mopidamol | MedChemExpress (MCE)
Mopidamol (RA 233), a derivative of Dipyridamole (HY-B0312), is a phosphodiesterase inhibitor. RA-233 can be used for non-small cell lung cancer (N-SCLC) research[1][2].

Trivial name | Mopidamol |
Catalog Number | HY-106618 |
Alternative Name(s) | RA 233 |
Research Area | Cancer |
CAS# | 13665-88-8 |
Purity | ≥98.0% |
SMILES | OCCN(C1=NC=C2C(C(N3CCCCC3)=NC(N(CCO)CCO)=N2)=N1)CCO |
Size | 1 mg |
Supplier Page | https://www.medchemexpress.com/mopidamol.html |